Search

Background and design: In this study, we aimed to identify whether there was an association of insulin resistance and metabolic syndrome with androgenetic alopecia (AGA) in reproductive women. Materials and methods: We investigated insulin resistance and metabolic syndrome, which is known to be associated with insulin-resistance, in 55 females with AGA (Ludwig I and above) who were under 45 years of age and 50 age-matched woman without AGA. We used homeostasis model assessment (HOMA) index and quantitative insulin sensitivity check index (QUICKI) to identify insulin resistance. The cut-off value for HOMA was accepted as 2.7. The diagnosis of metabolic syndrome was established using the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) criteria. Results: Serum fasting blood glucose levels were significantly higher in females with AGA than in controls (p<0.05). According to HOMA index, insulin resistance was determined in 11 of 55 (20%) patients in the AGA group, whereas it was identified in only 6 of 50 (12%) controls. The difference between the two groups was not statistically significant (p>0.05). The two groups were also compared for the levels of QUICKI. The mean levels of QUICKI in patient control groups were 0.36±0.04 and 0.36±0.03, respectively. The difference between the groups was not statistically significant (p>0.05). Finally, when the two groups were assessed according to the NCEP ATP III-criteria, metabolic syndrome was identified in 5 out of the 55 (9.1%) patients in the AGA group whereas none of participants had metabolic syndrome in control group. The difference between these groups was not statistically significant (p>0.05). Conclusion: In our study, it was shown that there was no significant relationship of insulin resistance and metabolic syndrome with AGA in women. (Turkderm 2015; 49: 134-8) [ABSTRACT FROM AUTHOR]